Filing Details
- Accession Number:
- 0001493152-18-008237
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-05 16:58:04
- Reporting Period:
- 2018-06-01
- Accepted Time:
- 2018-06-05 16:58:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1260641 | C James Czirr | C/O Galectin Therapeutics, Inc. 4960 Peachtree Industrial Blvd., Suite 240 Norcross, GA 30071 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-06-01 | 41,907 | $5.12 | 3,161,693 | No | 4 | S | Indirect | see footnote |
| Common Stock | Disposition | 2018-06-04 | 8,093 | $5.13 | 3,119,786 | No | 4 | S | Indirect | see footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | see footnote |
| No | 4 | S | Indirect | see footnote |
Footnotes
- The transaction was consummated by 10X Fund, L.P., a Delaware limited partnership, and not by the Reporting Person. The Reporting Person is a managing member of 10X Capital Management, LLC, a Florida limited liability company acting as the general partner of 10X Fund, L.P., and as such, may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. Mr. Czirr disclaims beneficial ownership of the reported securities except to the extent of his after fund payout pecuniary interest therein.
Billionaire Hedge Funds
